ConductScience.org, home

Paper39160243

Applications of cell therapy in the treatment of virus-associated cancers.

Toner K and 2 others. Nat Rev Clin Oncol, 2024. Cited by 22 papers, by iCite.

Cite this record

ConductScience Library. Applications of cell therapy in the treatment of virus-associated cancers. Papers, record 39160243. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39160243

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Applications of cell therapy in the treatment of virus-associated cancers.
PubMed
Journal
Nat Rev Clin Oncol
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
22
iCite
Relative citation ratio, by iCite
3.0, provisional
iCite
Revised in PubMed
2026-11-01
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Toner KKeri
2McCann CDChase D
3Bollard CMCatherine Mhttps://orcid.org/0000-0001-5140-9090

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
NeoplasmsMajor topic
Humans
Cell- and Tissue-Based Therapy
Virus Diseases
T-Lymphocytes
Oncogenic Viruses
Tumor Virus Infections

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
P01 CA148600NCI NIH HHSUnited StatesP01CA148600PubMed

Source NIH RePORTER

Download CSV of grants

References174

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123610374Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation.Blood2013https://conductscience.org/library/papers/23610374PubMed
220479287Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study.Blood2010https://conductscience.org/library/papers/20479287PubMed
329896681Vaccine Development for Epstein-Barr Virus.Adv Exp Med Biol2018https://conductscience.org/library/papers/29896681PubMed
41751370Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87).Br J Haematol1991https://conductscience.org/library/papers/1751370PubMed
538395437HBV integrations reshaping genomic structures promote hepatocellular carcinoma.Gut2024https://conductscience.org/library/papers/38395437PubMed
630249388HIV-Specific, Ex Vivo Expanded T Cell Therapy: Feasibility, Safety, and Efficacy in ART-Suppressed HIV-Infected Individuals.Mol Ther2018https://conductscience.org/library/papers/30249388PubMed
727470177Global burden of cancers attributable to infections in 2012: a synthetic analysis.Lancet Glob Health2016https://conductscience.org/library/papers/27470177PubMed
835919489Combination of genetically engineered T cells and immune checkpoint blockade for the treatment of cancer.Immunother Adv2022https://conductscience.org/library/papers/35919489PubMed
927207801T cells for viral infections after allogeneic hematopoietic stem cell transplant.Blood2016https://conductscience.org/library/papers/27207801PubMed
1038354149HIV-1 Remission after Allogeneic Hematopoietic-Cell Transplantation.N Engl J Med2024https://conductscience.org/library/papers/38354149PubMed
1119880495Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients.Blood2010https://conductscience.org/library/papers/19880495PubMed
1231219185T-cell receptor sequencing demonstrates persistence of virus-specific T cells after antiviral immunotherapy.Br J Haematol2019https://conductscience.org/library/papers/31219185PubMed
1337486263Recent Updates on Viral Oncogenesis: Available Preventive and Therapeutic Entities.Mol Pharm2023https://conductscience.org/library/papers/37486263PubMed
1437931422Vaccines for HPV-associated diseases.Mol Aspects Med2023https://conductscience.org/library/papers/37931422PubMed
1514729650Graft-versus-Tax response in adult T-cell leukemia patients after hematopoietic stem cell transplantation.Cancer Res2004https://conductscience.org/library/papers/14729650PubMed
1631102403Risk stratification of cervical lesions using capture sequencing and machine learning method based on HPV and human integrated genomic profiles.Carcinogenesis2019https://conductscience.org/library/papers/31102403PubMed
1737242405Mechanisms of Innate Immune Sensing of HTLV-1 and Viral Immune Evasion.Pathogens2023https://conductscience.org/library/papers/37242405PubMed
1819213682Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation.N Engl J Med2009https://conductscience.org/library/papers/19213682PubMed
193264384Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report.N Engl J Med1988https://conductscience.org/library/papers/3264384PubMed
2010910888Prolonged survival and tissue trafficking following adoptive transfer of CD4zeta gene-modified autologous CD4(+) and CD8(+) T cells in human immunodeficiency virus-infected subjects.Blood2000https://conductscience.org/library/papers/10910888PubMed

See all 174 referencesDownload CSV of references

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.

PMIDTitleJournalYearIn PapersSource
42751305HIV-driven tumor ecosystem: from chronic immune dysfunction to cancer evolution.Front Microbiol2026https://conductscience.org/library/papers/42751305PubMed
42707326SFRT alleviates symptoms associated with bulky advanced cancer: a retrospective single-center cohort analysis.Front Oncol2026https://conductscience.org/library/papers/42707326PubMed
41913941Neuroinflammation as a result of non-neurotropic herpesvirus infection.Immunol Cell Biol2026https://conductscience.org/library/papers/41913941PubMed
41902270Cell-Mediated Immunity Against Human Papillomavirus Infection: From Viral Clearance to Oncogenesis.Viruses2026https://conductscience.org/library/papers/41902270PubMed
41686909De novo identification of the specificities of recurrently identified human T cell receptors.Sci Adv2026https://conductscience.org/library/papers/41686909PubMed
41597848Theoretical Investigation of Early Cancer Biomarker Sensing Using a PMMA-Gold Hybrid Quasi-D-Shaped Photonic-Crystal-Fiber-Based Surface Plasmon Resonance Biosensor.Micromachines (Basel)2025https://conductscience.org/library/papers/41597848PubMed
41476298In vitro evaluation of bidirectional transcription levels of five types of non-coding control regions of Merkel cell polyomavirus.Virol J2025https://conductscience.org/library/papers/41476298PubMed
41369835Epstein-Barr virus and human MiRNAs crosstalk: orchestrating latency, lytic cycle, and immune system modulation.Folia Microbiol (Praha)2026https://conductscience.org/library/papers/41369835PubMed
41368235Guiding Antiviral Cell Therapy Approaches with an Online Resource of Clinically Scored Epitopes, T-Cell Receptors, and B-Cell Receptors.Transfus Med Hemother2025https://conductscience.org/library/papers/41368235PubMed
41004261Defective but tumorigenic: the evolutionary and functional roles of mutated oncoviruses.FEMS Microbiol Rev2025https://conductscience.org/library/papers/41004261PubMed
40969223Isolator-based point-of-care manufacturing: a practical solution for GMP-compliant cell and extracellular vesicles therapy production.Front Bioeng Biotechnol2025https://conductscience.org/library/papers/40969223PubMed
40864193Harnessing virus-specific T cells: expanding therapeutic strategies across diverse populations.Blood Adv2025https://conductscience.org/library/papers/40864193PubMed
40799546De novo identification of the specificities of recurrent human T cell receptors.bioRxiv2025https://conductscience.org/library/papers/40799546PubMed
40690075Research trends between acquired immune deficiency syndrome and hematological malignancies: a bibliometric analysis.Discov Oncol2025https://conductscience.org/library/papers/40690075PubMed
40350456Viral oncogenesis in cancer: from mechanisms to therapeutics.Signal Transduct Target Ther2025https://conductscience.org/library/papers/40350456PubMed
40007622Synchronous multiple primary cancers involving cervical cancer and follicular lymphoma: A case report.Oncol Lett2025https://conductscience.org/library/papers/40007622PubMed
39856423ImmunOctoberfest reloaded.Nat Immunol2025https://conductscience.org/library/papers/39856423PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39160243

GET https://conductscience.org/api/papers/v1/39160243/references?page=2